Ahmad Reza Bahrami Selected Research

Ahmad Reza Bahrami Research Topics

Disease

20	Neoplasms (Cancer) 03/2022 - 01/2012
5	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 10/2016
5	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2011
4	Colorectal Neoplasms (Colorectal Cancer) 10/2021 - 01/2019
4	Neoplasm Metastasis (Metastasis) 09/2016 - 10/2015
3	Hypoxia (Hypoxemia) 12/2020 - 01/2016
3	Carcinoma (Carcinomatosis) 07/2014 - 09/2012
3	Transitional Cell Carcinoma 03/2014 - 11/2011
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2014 - 03/2011
2	Inflammation (Inflammations) 01/2022 - 04/2021
2	Colonic Neoplasms (Colon Cancer) 01/2021 - 01/2019
2	Wounds and Injuries (Trauma) 02/2019 - 12/2018
2	Bone Fractures (Bone Fracture) 01/2019 - 01/2016
2	Cerebellar Diseases (Cerebellar Syndrome) 11/2011 - 11/2011
1	Adenocarcinoma 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Azoospermia 12/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	WHIM syndrome 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Genomic Instability 10/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2020
1	Cicatrix (Scar) 12/2018
1	Burns 12/2018
1	Leg Ulcer 12/2018
1	Starvation 11/2016
1	Schizophrenia (Dementia Praecox) 03/2016
1	Esophageal Neoplasms (Esophageal Cancer) 10/2015
1	Carcinogenesis 07/2015
1	Cartilage Diseases (Cartilage Disease) 10/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2014

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 03/2022 - 03/2011
4	EnzymesIBA 09/2021 - 10/2016
4	Chemokine ReceptorsIBA 09/2016 - 10/2015
3	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 03/2011
3	Biological ProductsIBA 12/2021 - 01/2012
3	Valproic Acid (Depakote)FDA LinkGeneric 12/2020 - 01/2016
3	Deferoxamine (Desferal)FDA LinkGeneric 12/2020 - 01/2016
3	Messenger RNA (mRNA)IBA 11/2016 - 01/2011
3	coumarinIBA 10/2016 - 01/2014
2	Ellagic AcidIBA 01/2022 - 02/2021
2	Amino Acids FDA Link 01/2021 - 02/2016
2	Peptides (Polypeptides)IBA 01/2021 - 01/2021
2	cobaltous chloride (cobalt(II)chloride)IBA 12/2020 - 01/2018
2	CoumarinsIBA 03/2020 - 01/2014
2	Long Noncoding RNAIBA 10/2019 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2016
2	CytokinesIBA 09/2012 - 01/2011
1	QuinolonesIBA 03/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	GelatinIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Epithelial Cell Adhesion MoleculeIBA 10/2021
1	APTIBA 10/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2021
1	Glycyrrhetinic Acid (Po 12)IBA 09/2021
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 09/2021
1	ProdrugsIBA 09/2021
1	Lipoxygenase InhibitorsIBA 05/2021
1	LipoxygenasesIBA 05/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	InterferonsIBA 01/2021
1	LigandsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	CXC ChemokinesIBA 01/2021
1	AntibodiesIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 03/2020
1	stylosinIBA 12/2019
1	Monoterpenes (Monoterpenoids)IBA 12/2019
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 12/2019
1	resazurinIBA 12/2019
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 12/2019
1	CollagenIBA 02/2019
1	Small Nucleolar RNA (snoRNA)IBA 01/2019
1	ChitosanIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Calcium Gluconate (CBG)IBA 01/2019
1	HydrogelsIBA 01/2019
1	Aligeron (AS 2)IBA 01/2019
1	Interleukin-33IBA 03/2016
1	Myeloid Ecotropic Viral Integration Site 1 ProteinIBA 02/2016
1	AlkaloidsIBA 02/2016
1	BerberineIBA 02/2016
1	ChemokinesIBA 02/2016
1	Biocompatible Materials (Biomaterials)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 07/2015
1	Formaldehyde (Formol)FDA Link 07/2015
1	4-oxy-6-(4-oxybezoyloxy)dauc-8,9-enIBA 07/2014
1	SesquiterpenesIBA 07/2014
1	diversinIBA 03/2014
1	3- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA 03/2014

Therapy/Procedure

14	Therapeutics 10/2021 - 02/2014
5	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 11/2011
3	Drug Therapy (Chemotherapy) 09/2021 - 03/2014
2	Radiotherapy 01/2022 - 09/2021
2	Immunomodulation 04/2021 - 01/2021
2	Transplantation 05/2014 - 11/2011
1	Immunotherapy 01/2021
1	Intravenous Administration 05/2014